| Members |
targetComponentId |
| Multiple-level cervical spondylosis with radiculopathy |
Radiculopathy due to multiple-level cervical spondylosis |
| Multivitamin preparation |
Multivitamin agent (substance) |
| Multivitamin preparations |
Multivitamin agent (substance) |
| Multivitamin+mineral preparations |
Multivitamin multimineral supplement (substance) |
| Multivitamin+mineral preparations |
Multivitamin multimineral supplement (substance) |
| Multivitamins |
Multivitamin agent (substance) |
| Mumps - other |
Mumps |
| Mumps - other |
Mumps |
| Mumps with complication |
Mumps |
| Mumps with other specified complication |
Mumps |
| Mumps-measles-rubella not given |
Measles mumps and rubella vaccination not done (situation) |
| Mupirocin calcium 2% cream |
Mupirocin (as mupirocin calcium) 20 mg/mL cutaneous cream |
| Mural cardiac aneurysm |
Aneurysm of heart |
| Mural cardiac aneurysm |
Aneurysm of heart |
| Muscle bridge |
Reconstruction using flap (procedure) |
| Muscle relaxants |
Skeletal muscle relaxant (substance) |
| Muscle transfer for claw toe repair |
Transfer of flexor to extensor tendon of lesser toe |
| Muscle, ligament or fascia disorder NOS |
Muscle, ligament and fascia disorders |
| Muscular calcification |
Muscular ossification |
| Muscular wasting and disuse atrophy, NEC |
Muscle atrophy |
| Musculoskel X-ray abnorm [D] |
Plain X-ray of musculoskeletal system abnormal (finding) |
| Musculoskeletal problems NOS |
Disorder of musculoskeletal system |
| Musculoskeletal problems NOS |
Disorder of musculoskeletal system |
| Musculoskeletal system diagnostic imaging procedure |
Imaging of musculoskeletal system (procedure) |
| Mushroom |
Order Agaricales |
| Mushroom - dietary |
Mushroom (substance) |
| Mustard - dietary |
Mustard seasoning (substance) |
| Mutase |
Mutase |
| Mycobacterium aquae |
Mycobacterium gordonae |
| Mycobacterium bolletii |
Mycobacteroides abscessus subspecies abscessus (organism) |
| Mycobacterium chelonae ss. abscessus |
Mycobacteroides abscessus (organism) |
| Mycobacterium chlorophenolicus |
Mycobacterium chlorophenolicum |
| Mycobacterium margeritense |
Mycobacterium mageritense (organism) |
| Mycobacterium, MAIS group |
Mycobacterium, avium-intracellulare group |
| Mycophenolic acid 180mg m/r capsule |
Mycophenolic acid (as mycophenolate sodium) 180 mg gastro-resistant oral tablet |
| Mycophenolic acid 360mg m/r capsule |
Mycophenolic acid (as mycophenolate sodium) 360 mg gastro-resistant oral tablet |
| Mycoplana bullata |
Brevundimonas bullata (organism) |
| Mycoplasma ellychniae |
Entomoplasma ellychniae |
| Mycoplasma lactucae |
Mesoplasma lactucae |
| Mycoplasma lepcaptivus |
Mycoplasma leonicaptivi (organism) |
| Mycoplasma lucivorax |
Entomoplasma lucivorax |
| Mycoplasma melaleucae |
Entomoplasma melaleucae |
| Mycoplasma somnilux |
Entomoplasma somnilux |
| Mycoplasma weynonii |
Mycoplasma wenyonii (organism) |
| Mycosis fungoides of extranodal AND/OR solid organ site |
Mycosis fungoides (clinical) |
| Mycosis fungoides of lymph nodes of axilla AND/OR upper limb |
Mycosis fungoides of lymph nodes of upper limb (disorder) |
| Mycosis fungoides of lymph nodes of axilla and upper limb |
Mycosis fungoides of lymph nodes of upper limb (disorder) |
| Mycosis leptothrica |
Tonsillitis caused by Gram negative bacteria |
| Mycotic aneurysm due to bacterial endocarditis |
Endocarditis with infective aneurysm |
| Myelinated retinal nerve fibres |
Myelinated nerve fiber layer of retina |
| Myelinated retinal nerve fibres |
Myelinated nerve fiber layer of retina |
| Myelodysplasia |
Myelodysplasia of spinal cord |
| Myelodysplastic syndrome with multilineage dysplasia |
Myelodysplastic syndrome with low blasts (disorder) |
| Myelodysplastic syndrome with multilineage dysplasia |
Myelodysplastic neoplasm with low blasts (morphologic abnormality) |
| Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myelodysplastic syndrome with single lineage dysplasia |
Myelodysplastic syndrome with low blasts (disorder) |
| Myelodysplastic syndrome with single lineage dysplasia |
Myelodysplastic neoplasm with low blasts (morphologic abnormality) |
| Myelodysplastic syndrome: Refractory anemia, without ringed sideroblasts, without excess blasts |
Myelodysplastic syndrome with low blasts (disorder) |
| Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myeloid leukemia - category |
Myeloid leukaemia |
| Myeloid leukemia, no International Classification of Diseases for Oncology subtype |
Myeloid leukaemia |
| Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement |
Myeloid/lymphoid neoplasm with PDGFRB rearrangement |
| Myeloproliferative disease, no ICD-O subtype |
Myeloid proliferation |
| Myelosclerosis |
Myelofibrosis |
| Myelosclerosis with myeloid metaplasia |
Primary myelofibrosis |
| Myocardial infarction clinical management plan |
Myocardial infarction clinical management plan (record artifact) |
| Myocarditis NOS |
Myocarditis |
| Myocarditis NOS |
Myocarditis |
| Myoma, no International Classification of Diseases for Oncology subtype |
Myoma |
| Myometrial hyperplasia |
Hyperplasia of myometrium (disorder) |
| Myotenontoplasty |
Myotenoplasty |
| Myotenoplasty of hand |
Myotenoplasty |
| Myotension technique |
Muscle energy technique (procedure) |
| Myovirus group |
Family Myoviridae (organism) |
| Myringotomy including aspiration with general anesthesia |
Administration of anesthesia (procedure) |
| N-b-bis (2-chloroethyl)-2-naphthylamine |
Chlornaphazine (substance) |
| N0 category |
American Joint Committee on Cancer cN0 (qualifier value) |
| N1: Metastasis in 1-3 lymph nodes |
cN1 |
| N1: Metastasis in 1-6 perigastric lymph nodes |
cN1 |
| N1: Metastasis in a single ipsilateral lymph node, < 3 cm in greatest dimension |
cN1 |
| N1: Metastasis in a single lymph node |
cN1 |
| N1: Metastasis in a single lymph node, < 2 cm in greatest dimension |
cN1 |
| N1: Metastasis in a single lymph node, <= 2 cm in greatest dimension |
cN1 |
| N1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumor |
cN1 |
| N1: Metastasis in perirectal lymph node or nodes |
cN1 |
| N1: Metastasis in regional lymph node or nodes |
cN1 |
| N1: Metastasis to movable ipsilateral axillary lymph node(s) |
cN1 |
| N1: Metastasis with a lymph node mass less than 2 cm in greatest dimension and 5 or fewer positive nodes, none larger than 2 cm in greatest dimension |
cN1 |
| N1: Pelvic or inguinal lymph node metastasis |
cN1 |
| N1: Regional lymph node metastasis |
cN1 |
| N1: Unilateral metastasis in lymph node(s) > 6 cm in greatest dimension, above supraclavicular fossa |
cN1 |
| N1a: 1-3 nodes involved |
American Joint Committee on Cancer cN1a (qualifier value) |
| N1a: Metastasis in ipsilateral cervical lymph node(s) |
American Joint Committee on Cancer cN1a (qualifier value) |
| N1a: Metastasis in single regional lymph node |
American Joint Committee on Cancer cN1a (qualifier value) |
| N1a: Only micrometastasis, none > 0.2 cm in greatest dimension |
American Joint Committee on Cancer cN1a (qualifier value) |
| N1b: 4-7 nodes involved |
American Joint Committee on Cancer cN1b (qualifier value) |
| N1b: Metastasis in bilateral, midline, or contralateral cervical or mediastinal lymph node(s) |
American Joint Committee on Cancer cN1b (qualifier value) |
| N1b: Metastasis in multiple regional lymph nodes |
American Joint Committee on Cancer cN1b (qualifier value) |
| N1b: Metastasis to lymph node(s), any > 0.2 cm in greatest dimension |
American Joint Committee on Cancer cN1b (qualifier value) |
FHIR